Stroke prevention in atrial fibrillation: another step sideways.
Go
Alan S
AS
Division of Research, Kaiser Permanente of Northern California, Oakland, CA 94612, USA. alan.s.go@kp.org
Singer
Daniel E
DE
D000925:Anticoagulants / Q000009:adverse effects / Q000627:therapeutic use*; D001281:Atrial Fibrillation / Q000188:drug therapy*; D006470:Hemorrhage / Q000139:chemically induced; D006801:Humans; D009844:Oligosaccharides / Q000009:adverse effects / Q000627:therapeutic use*; D020521:Stroke / Q000517:prevention & control*; D013923:Thromboembolism / Q000517:prevention & control; D014812:Vitamin K / Q000037:antagonists & inhibitors*; D014859:Warfarin / Q000009:adverse effects / Q000627:therapeutic use
D000925:Anticoagulants; D009844:Oligosaccharides; D014812:Vitamin K; D014859:Warfarin; C479958:idraparinux